DIA DiaSorin S.p.A.
75.92EUR+1.36%Mkt Cap: 4.08B $P/E: 27.91Today
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiag…
Industry Peers
Diagnostics & Research$242.11BUSDP/E 35.5
$150.48BUSDP/E 38.2
$59.15BUSD
$45.82BUSDP/E 38.1
$47.30BUSDP/E 33.1
$42.50BUSDP/E 32.2
$41.75BUSDP/E 107.4
$41.23BUSDP/E 50.8
$40.89BUSDP/E 36.4
$29.78BUSDP/E 34.0
$25.75BUSDP/E 25.0
$25.02BUSDP/E 25.5
$23.86BUSD
$16.91BUSDP/E 72.5
$16.73BUSDP/E 35.2
$14.05BUSDP/E 26.2
$13.85BUSD
$12.50BUSDP/E 249.3
$10.02BUSDP/E 20.0
$9.24BUSDP/E 22.7
| Headline | Source | Time |
|---|---|---|
Today | ||
Older | ||
Diasorin SpA (DSRLF) (H1 2026) Earnings Call Highlights: Return to Growth, Strong U.S. ... Diasorin SpA (DSRLF) reports a 4% revenue increase in Q2 2026, driven by a U.S. immunodiagnostics recovery and strong Liaison Plex traction, while navigating China declines and tariff headwinds. | ||
QQuotazioni, Borsa, Economia e Finanza | ||